Kanaly Trust’s AstraZeneca AZN Stock Holding History

Kanaly Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1M	Buy	18,329 +1,479	+9%	+$84K	0.21%	54
2016 Q3	$1.11M	Buy	16,850 +15,940	+1,752%	+$1.04M	0.23%	58
2016 Q2	$55K	Sell	910 -38	-4%	-$2.21K	0.01%	273
2016 Q1	$53K	Sell	948 -26	-3%	-$1.56K	0.01%	282
2015 Q4	$66K	Hold	974	–	–	0.01%	252
2015 Q3	$62K	Hold	974	–	–	0.01%	259
2015 Q2	$62K	Buy	974 +222	+30%	+$15.2K	0.01%	277
2015 Q1	$51K	Sell	752 -128	-15%	-$8.89K	0.01%	283
2014 Q4	$62K	Buy	880 +21	+2%	+$1.5K	0.01%	271
2014 Q3	$61K	Hold	859	–	–	0.01%	275
2014 Q2	$64K	Sell	859 -25,608	-97%	-$1.85M	0.01%	283
2014 Q1	$1.72M	Sell	26,467 -2,557	-9%	-$165K	0.33%	41
2013 Q4	$1.72M	Buy	+29,024	New	+$1.58M	0.34%	38

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Kanaly Trust's AZN Position: Q4 2016 in Review

Kanaly Trust increased its AstraZeneca (AZN) stake by 8.8% in Q4 2016, buying an estimated $84K and bringing the position to 18,329 shares worth $1M. The position accounts for 0.21% of the portfolio, ranked #54.

Kanaly Trust first reported a position in AZN in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.72M in Q4 2013. 449 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

Kanaly Trust held 18,329 shares of AstraZeneca worth $1M as of Q4 2016.
Kanaly Trust bought 1,479 AstraZeneca shares in Q4 2016, an estimated $84K.
AstraZeneca made up 0.21% of Kanaly Trust's portfolio in Q4 2016, its #54 holding.
Kanaly Trust first reported a position in AstraZeneca in Q4 2013 and has held it in 13 quarters since.
Kanaly Trust's AstraZeneca position peaked at $1.72M in Q4 2013.
449 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.